Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks
Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
Start Today
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //
Register
AdChoices
Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time
Alerts Watchlist Portfolio

Today's Trading

Day Low 265.49
Day High 294.74
Open:265.49
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Latest
investment ideas
‘Stay-at-home’ trade still has legs in 2021: top mutual fund managers
Subscriber content
inside the market
Gordon Pape: How my pandemic stock picks performed in a year unlike any other
Subscriber content
top links
Top stock picks in the red-hot medical technology sector
Subscriber content
inside the market
Gordon Pape: More predictions on what life will look like after the pandemic (and the stocks that will benefit)
Subscriber content
top links
21 stocks for the ‘COVID economy’
Subscriber content
investor newsletter
The enormous investment opportunity in med tech, Dollarama’s very bad day, and a vitamin stock analysts love
Description
Teladoc, Inc. is a telehealth company. The company offers telehealth services via mobile devices, internet, video and phone to clients primarily in the United States. Its solution connects consumers with physicians and behavioral health professionals to treat upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. Teladoc, Inc. is based in Dallas, Texas.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

View Earnings zacks

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy
View Estimates zacks

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDF Refinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDF StockCalc

Latest Press Releases

More Stories
Teladoc Inc Set to Possibly Pullback After Yesterday's Rally of 5.22%
- Comtex SmarTrend(R) - Wed Jan 20, 10:58AM CST
Comtex SmarTrend(R) - CMTX
Wed Jan 20, 10:58AM CST
Teladoc Inc (NYSE:TDOC) traded in a range yesterday that spanned from a low of $234.20 to a high of $251.12. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $233.67 on volume of 2.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Teladoc Health Issues Inaugural Corporate Social Responsibility Report
- GlobeNewswire - Thu Jan 14, 6:15AM CST
GlobeNewswire - CMTX
Thu Jan 14, 6:15AM CST
Teladoc Health, the first and only comprehensive virtual care system, today released its 2020 Corporate Social Responsibility (CSR) Report, which highlights the company's commitment to taking care of people, building trust, operating responsibly and having a positive impact on global communities. Through its inaugural CSR report, Teladoc Health sets an industry precedent for the ongoing commitment to corporate social responsibility, transparency and reporting.
Leading $2.8 Trillion US Healthcare Market: CEO's of 1life Healthcare, Skylight Health, Veeva Systems, and Teladoc - Driving Explosive Revenue Growth with Innovation and New Market Expansions
- GlobeNewswire - Tue Jan 12, 9:28AM CST
GlobeNewswire - CMTX
Tue Jan 12, 9:28AM CST
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: 1life Healthcare (NASDAQ: ONEM), Skylight Health Group (TSX.V: SHG) (OTC: SHGFF) Teladoc Health (NYSE: TDOC), and Veeva Systems (NYSE: VEEV).
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 192.00 +49.53% increase
on 01/04/21
Period Open:207.95
Price movement based on the high, low and last over the given period.
294.74 -2.60% decrease
on 01/25/21
 +79.14 (+38.06%) increase
since 12/24/20
3-Month 168.50 +70.38% increase
on 11/10/20
Period Open:216.32
Price movement based on the high, low and last over the given period.
294.74 -2.60% decrease
on 01/25/21
 +70.77 (+32.72%) increase
since 10/23/20
52-Week 93.56 +206.85% increase
on 01/27/20
Period Open:98.10
Price movement based on the high, low and last over the given period.
294.74 -2.60% decrease
on 01/25/21
 +188.99 (+192.65%) increase
since 01/24/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies